Orthopedic And Rheumatic Immune
Osteoarthritis is a chronic degenerative osteoarthrosis disease, which has become the second largest disease leading to the disability. With the progress of population aging in China, the number of these patients has exceeded 600 million, seriously impacting the quality of life of people.
Chronic musculoskeletal pain has become a major public health problem in the world. And the chronic low back pain, knee osteoarthritis, neck pain and hip osteoarthritis are the most common types. The prevalence of these types in the elderly in China are 48%, 31%, 22.5% and 8.9% respectively, seriously impacting the physical and mental health of these patients.
Kaixi (Etoricoxib Tablets)of Tide Pharmaceuticaol is the latest generation of selective cyclooxygenase-2 (COX-2) inhibitors, which has anti-inflammatory, analgesic and antipyretic effects, relieving pain and bringing more therapeutic options for patients with osteoarthritis.
NAME OF THE DRUG
【GENERIC NAME】: Flurbiprofen Cataplasms
【TRADE NAME】:Debaian
【Indications】
Analgesia and anti-inflammation for the following diseases and symptoms:
Osteoarthritis, scapulohumeral periarthritis, myotenositis and tenosynovitis, periarthritis of tendon sheath, external humeral epicondylitis (tennis elbow), muscle pain, and swelling and pain caused by trauma.
【Description】
The cataplasm surface of this product is white or yellowish, the cataplasm is evenly laid on the back lining, and the cataplasm surface is covered with a film.
【Strength】
Each paste contains 40 mg flurbiprofen (with an area of 13.6 cm×10.0 cm, containing 12 g of cataplasm).
【Dosage and Administration】
Twice daily, applied to the affected area.
NAME OF THE DRUG
【GENERIC NAME】: Flurbiprofen Cataplasms
【TRADE NAME】:Zepusi
【Indications】
Analgesia and anti-inflammation for the following diseases and symptoms:
Osteoarthritis, scapulohumeral periarthritis, myotenositis and tenosynovitis, periarthritis of tendon sheath, external humeral epicondylitis (tennis elbow), muscle pain, and swelling and pain caused by trauma.
【Description】
The cataplasm surface of this product is white or yellowish, the cataplasm is evenly laid on the back lining, and the cataplasm surface is covered with a film.
【Strength】
Each paste contains 40 mg flurbiprofen (with an area of 13.6 cm×10.0 cm, containing 12 g of cataplasm).
【Dosage and Administration】
Twice daily, applied to the affected area.
Debaian (Flurbiprofen Cataplasms)
Zepusi (Flurbiprofen Cataplasms)
®
®
®
NAME OF THE DRUG
【GENERIC NAME】: Etoricoxib Tablets
【TRADE NAME】:Kaixi
【Indications】
This product is suitable for:
-treatment of symptoms and signs of acute and chronic osteoarthritis.
-treatment of acute gouty arthritis.
-treatment of primary dysmenorrhea.
Prescription selective cyclooxygenase-2 inhibitors should be based on a comprehensive assessment of individual patient risk (see [notes])
【Description】
This product is a green film-coated tablet, which shows white to light yellow after removing the coating.
【Strength】
(1)30mg (2)60mg
【Dosage and Administration】
This product is for oral use and can be taken with food or alone. This product should be given in the lowest daily dose and in the shortest possible time.
Please refer to the product manual for details.
Kaixi (Etoricoxib Tablets)
®
CONTACT US
Address: 8 Rongjing East Street, Beijing Economic Technological Development Area, 100176, China
Telephone:010-67880648
Medical consultation and adverse reaction reports
Telephone:010-67870530(weekday8:30-17:00)
E-mail:pv@tidepharm.com
Copyright: Beijing Tide Pharmaceutical Co., Ltd 京ICP备05013257号
京公网安备110301000319号 互联网药品信息服务资格证书编号: (京)-非经营性-2014-0076